Cargando…

Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis

Objective To investigate predictive biomarkers correlated with the onset of hepatorenal syndrome (HRS) in individuals with alcoholic liver cirrhosis using various factors, including age, sex, and laboratory indicators such as serum sodium, bilirubin, PT/INR, and albumin levels. Additionally, we soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deorukhkar, Durga, Sonawale, Archana, Goyal, Aman, Sonawale, Kshitij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684394/ https://www.ncbi.nlm.nih.gov/pubmed/38034151 http://dx.doi.org/10.7759/cureus.47927

Ejemplares similares

A Rare Case of Disseminated Histoplasmosis in an Adult With Alcoholic Liver Cirrhosis
por: Kozyk, Marko, et al.
Publicado: (2023)

Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
por: Umar, Zaryab, et al.
Publicado: (2022)

Pulmonary Hypertension as a Rare Complication After Orthotopic Liver Transplant in a Patient With Non-alcoholic Steatohepatitis (NASH) Cirrhosis Complicated by Hepatopulmonary Syndrome
por: Dadlani, Apaar, et al.
Publicado: (2022)

Predictors and Outcomes of Infections in ICU Patients With Cirrhosis: A Single-Center Observational Study
por: Kulkarni, Anand, et al.
Publicado: (2023)

Clostridium tertium Bacteremia in a Non-neutropenic Patient with Liver Cirrhosis
por: Wazir, Mohammed, et al.
Publicado: (2019)

Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018
por: Singh, Jagmeet, et al.
Publicado: (2021)

Lactobacillus-Associated Spontaneous Bacterial Peritonitis in a Liver Cirrhosis Patient on Probiotics
por: Ramachandran, Lintu, et al.
Publicado: (2020)

Dry Beriberi Manifesting as Acute Inflammatory Demyelinating Polyneuropathy in a Patient With Decompensated Alcohol-Induced Cirrhosis
por: Dhaliwal, Amaninder, et al.
Publicado: (2020)

The Pattern of Alcohol Consumption and the Severity of Alcohol-related Liver Disease in Patients Visiting the Liver Clinic
por: Ali Samjo, Shoukat, et al.
Publicado: (2020)

Spontaneous Bacterial Peritonitis Secondary to Salmonella spp. in a Patient With Decompensated Liver Cirrhosis
por: El Jurdi, Katia, et al.
Publicado: (2021)

Hepatocellular Carcinoma in Patients With Liver Cirrhosis Secondary to Autoimmune Hepatitis: A Case Series and Literature Review
por: Perera Mesa, Hassan, et al.
Publicado: (2022)

Safety and Efficacy of Endoscopic Retrograde Cholangio-Pancreatography in Patients of Liver Cirrhosis: A Case-Control Study
por: Vashishtha, Chitranshu, et al.
Publicado: (2023)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Clostridium difficile Infection in Liver Cirrhosis Carries a Higher Risk of Mortality: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019)

A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis
por: Xing, Yueyi, et al.
Publicado: (2022)

Hepatic Sarcoidosis: An Uncommon Cause of Cirrhosis
por: Ghoneim, Sara, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias
por: Mangi, Muhammad A, et al.
Publicado: (2017)

Management of hepatorenal syndrome in liver cirrhosis: a recent update
por: Bera, Chinmay, et al.
Publicado: (2022)

Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram
por: Mangi, Muhammad A, et al.
Publicado: (2017)

The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease
por: Kapila, Nikhil, et al.
Publicado: (2018)

A Complex Diagnosis of Ampullary Adenocarcinoma Presenting As Decompensated Cirrhosis
por: Iqbal, Humzah, et al.
Publicado: (2023)

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
por: Kerbert, Annarein J. C., et al.
Publicado: (2015)

Perception of Non-Alcoholic Fatty Liver Disease: Real-Life Experience From Pakistan
por: Butt, Nazish, et al.
Publicado: (2021)

Efficacy and Safety of Sofosbuvir-Velpatasvir combination in Hepatitis C Virus-infected Pakistani Patients without Cirrhosis or with Compensated Cirrhosis: A Prospective, Open-label Interventional Trial
por: Butt, Nazish, et al.
Publicado: (2020)

Implementing Better Standard Instruments for Detecting Cirrhosis in Hepatitis C Patients
por: Fagala, Mark D, et al.
Publicado: (2023)

Acquired Portosystemic Shunts in Cirrhosis and Portal Vein Thrombosis: A Case Report
por: Durgham, Anthony, et al.
Publicado: (2022)

Deranged Tyrosine Metabolism in Cirrhosis
por: Fulenwider, J. Timothy, et al.
Publicado: (1978)

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome
por: Heinrich, Sophia, et al.
Publicado: (2022)

Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study
por: Paudel, Mukesh S, et al.
Publicado: (2019)

Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B
por: Sharif, Asim, et al.
Publicado: (2019)

A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis
por: Xie, Yanan, et al.
Publicado: (2022)

Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity
por: Medina Pizaño, Mariana Yazmin, et al.
Publicado: (2023)

Optimal management of hepatorenal syndrome in patients with cirrhosis
por: Angeli, Paolo, et al.
Publicado: (2010)

Acute kidney injury and hepatorenal syndrome in cirrhosis
por: Gupta, Kapil, et al.
Publicado: (2021)

Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma
por: Gala, Khushboo, et al.
Publicado: (2020)

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion
por: Weersink, Rianne A, et al.
Publicado: (2016)

Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
por: Ratib, Sonia, et al.
Publicado: (2017)

Ganoderma lingzhi (Reishi Mushroom)-Induced Acute Liver Injury in the Setting of Alcohol Use: A Case Report and Review of the Literature
por: Guedikian, Roupen, et al.
Publicado: (2023)

Saroglitazar in Non-alcoholic Fatty Liver Disease From Bench to Bedside: A Comprehensive Review and Sub-group Meta-Analysis
por: Roy, Akash, et al.
Publicado: (2023)

Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome
por: Chiang, Chi-Wen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mm6hi99qn5rro3gdjmtr5mf1vb